XML 44 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents the fair value of the Company’s financial instruments segregated by the hierarchy level of the fair value estimate that are measured at fair value on a recurring basis as of the dates indicated:
 
December 31, 2017
 
Fair Value
 
Level 1 - Unadjusted Quoted Prices in Active Markets
 
Level 2 - Observable Inputs
 
Level 3 - Unobservable Inputs
Assets carried at fair value:
 
 
 
 
 
 
 
Investments in securities:
 
 
 
 
 
 
 
Mortgage-backed securities
$
3,026,989

 
$

 
$
3,019,746

 
$
7,243

U.S. Treasuries
146,530

 
146,530

 

 

Derivative assets:
 
 
 
 
 
 
 
Interest rate swaps
791

 

 
791

 

Eurodollar futures
666

 
666

 

 

TBA securities
1,483

 

 
1,483

 

Total assets carried at fair value
$
3,176,459

 
$
147,196

 
$
3,022,020

 
$
7,243

 
 
 
 
 
 
 
 
Liabilities carried at fair value:
 

 
 

 
 

 
 

TBA securities
269

 

 
269

 

Total liabilities carried at fair value
$
269

 
$

 
$
269

 
$

 
 
 
 
 
 
 
 
 
December 31, 2016
 
Fair Value
 
Level 1 - Unadjusted Quoted Prices in Active Markets
 
Level 2 - Observable Inputs
 
Level 3 - Unobservable Inputs
Assets carried at fair value:
 
 
 
 
 
 
 
Mortgage-backed securities
$
3,212,084

 
$

 
$
3,201,157

 
$
10,927

Interest rate swaps
28,534

 

 
28,534

 

Total assets carried at fair value
$
3,240,618

 
$

 
$
3,229,691

 
$
10,927

Liabilities carried at fair value:
 
 
 
 
 
 
 
Interest rate swaps
$
6,922

 
$

 
$
6,922

 
$

Total liabilities carried at fair value
$
6,922

 
$


$
6,922

 
$


Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
The activity of the Company’s non-Agency MBS measured at fair value on a recurring basis using Level 3 inputs is presented in the following table for the periods indicated:
 
Year Ended
 
December 31,
 
2017
 
2016
 
2015
Balance as of beginning of period
$
10,927

 
$
16,435

 
$
43,957

Unrealized (loss) gain included in OCI (1)
(1,733
)
 
(1,057
)
 
2,608

Principal payments
(4,351
)
 
(6,019
)
 
(30,602
)
Accretion
2,400

 
1,568

 
472

Balance as of end of period
$
7,243

 
$
10,927

 
$
16,435


(1)
Amount included in “unrealized gain (loss) on available-for-sale investments, net” on consolidated statements of comprehensive income (loss).

Fair Value, by Balance Sheet Grouping
The following table presents a summary of the carrying value and estimated fair values of the Company’s financial instruments as of the dates indicated:
 
December 31, 2017
 
December 31, 2016
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
Assets:
 
 
 
 
 
 
 
Mortgage-backed securities
$
3,026,989

 
$
3,026,989

 
$
3,212,084

 
$
3,212,084

U.S. Treasuries
146,530

 
146,530

 

 

Mortgage loans held for investment, net (1)
15,738

 
12,973

 
19,036

 
15,971

Derivative assets
2,940

 
2,940

 
28,534

 
28,534

Liabilities:
 

 
 

 
 

 
 

Repurchase agreements (2)
$
2,565,902

 
$
2,565,902

 
$
2,898,952

 
$
2,898,952

Non-recourse collateralized financing (1)
5,520

 
5,554

 
6,440

 
6,357

Derivative liabilities
269

 
269

 
6,922

 
6,922


(1)
The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.
(2)
The carrying value of repurchase agreements generally approximates fair value due to their short term maturities.